These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The relativity of vascular endothelium growth factor receptor-1 and preeclampsia]. Zou CL, Liu XH, Yue BM, Fu JH, He GL. Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):765-8. PubMed ID: 17037747 [Abstract] [Full Text] [Related]
8. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers. Tsao PN, Wei SC, Su YN, Chou HC, Chen CY, Hsieh WS. Pediatrics; 2005 Aug; 116(2):468-72. PubMed ID: 16061605 [Abstract] [Full Text] [Related]
9. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonçalves LF, Gomez R, Edwin S. Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729 [Abstract] [Full Text] [Related]
10. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Ahmad S, Ahmed A. Circ Res; 2004 Oct 29; 95(9):884-91. PubMed ID: 15472115 [Abstract] [Full Text] [Related]
15. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia. Wierzbowska A, Robak T, Wrzesień-Kuś A, Krawczyńska A, Lech-Marańda E, Urbańska-Ryś H. Eur Cytokine Netw; 2003 May 29; 14(3):149-53. PubMed ID: 14656688 [Abstract] [Full Text] [Related]
16. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy. Catarino C, Rebelo I, Belo L, Rocha S, Castro EB, Patrício B, Quintanilha A, Santos-Silva A. Growth Factors; 2009 Dec 29; 27(6):345-51. PubMed ID: 19919522 [Abstract] [Full Text] [Related]